216
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis of novel pyridine and pyrimidine thioglycoside phosphoramidates for the treatment of COVID-19 and influenza A viruses

, , &
Pages 851-877 | Received 19 Sep 2021, Accepted 29 May 2022, Published online: 23 Jun 2022

References

  • Bai, L.; Zhao, Y.; Dong, J.; Liang, S.; Guo, M.; Liu, X.; Wang, X.; Huang, Z.; Sun, X.; Zhang, Z.; et al. Coinfection with Influenza a Virus Enhances SARS-CoV-2 Infectivity. Cell Res. 2021, 31, 395–403. DOI: 10.1038/s41422-021-00473-1.
  • Cunningham, C. H.; Stuart, H. O. Cultivation of the Virus of Infectious Bronchitis of Chickens in Embryonated Chicken Eggs. Am. J. Vet. Res. 1947, 8, 209–212.
  • Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; et al. A Novel Coronavirus from Patients with Pneumonia in China. N Engl. J. Med. 2020, 8, 727–733.
  • Rota, P. A.; Oberste, M. S.; Monroe, S. S.; Nix, W. A.; Campagnoli, R.; Icenogle, J. P.; Peñaranda, S.; Bankamp, B.; Maher, K.; Chen, M.-H.; et al. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. Science 2003, 300, 1394–1399. DOI: 10.1126/science.1085952.
  • Zaki, A. M.; Boheemen, S. V.; Bestebroer, T. M.; Osterhaus, A. D.; Fouchier, R. A. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N. Engl. J. Med 2012, 19, 1814–1820.
  • Tang, B.; Bragazzi, N. L.; Li, Q.; Tang, S.; Xiao, S.; Wu, J. An Updated Estimation of the Risk of Transmission of the Novel Coronavirus (2019-nCov). Infect. Dis. Model. 2020, 5, 248–255.
  • Wang, J. T.; Chang, S. C. Severe Acute Respiratory Syndrome. Curr. Opin. Infect. Dis. 2004, 17, 143–148. DOI: 10.1097/00001432-200404000-00013.
  • Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. DOI: 10.1016/S0140-6736(20)30183-5.
  • Wang, C.; Horby, P. W.; Hayden, F. G.; Gao, G. F. A Novel Coronavirus Outbreak of Global Health Concern. Lancet 2020, 395, 470–473. DOI: 10.1016/S0140-6736(20)30185-.
  • Riel, D. V.; Munster, V. J.; Wit, E.; Guus, F. R.; Ron, A. M. F.; Albert, D.; Kuiken, T. Human and Avian Influenza Viruses Target Different Cells in the Lower Respiratory Tract of Humans and Other Mammals. Am. J. Pathol. 2007, 171, 1215–1223.
  • St. John, A. L.; Rathore, A. P. S. Early Insights into Immune Responses during COVID-19. J. Immunol. 2020, 205, 555–564. DOI: 10.4049/jimmunol.2000526.
  • a) Wang, M.; Cao, R.; Zhang, L.; Yang, X.; Liu, J.; Xu, M.; Shi, Z.; Hu, Z.; Zhong, W.; Xiao, G. Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro.Cell Res. 2020, 30,269, 271. b) Mahase, E. Covid-19: Pfizer’s Paxlovid is 89% Effective in Patients at Risk of Serious Illness, Company Reports. BMJ. 2021, 375:n2713. DOI: 10.1038/s41422-020-0282-0.
  • Bhupender, S.; Chhikara, B. R.; Jyoti, S. P. Corona Virus SARS-CoV-2 Disease COVID-19: Infection, Prevention and Clinical Advances of the Prospective Chemical Drug Therapeutics. Chem. Biol. Lett. 2020, 7, 63–72.
  • Yoon, J. J.; Toots, M.; Lee, S.; Lee, M. E.; Ludeke, B.; Jasmina, M. L.; Ganti, K.; Cox, R. M.; Sticher, Z. M.; Edpuganti, V.; et al. Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses. Antimicrob. Agents Chemother. 2018, 62, 766–718. DOI: 10.1128/AAC.00766-18.
  • Toots, M.; Yoon, J. J.; Cox, R. M.; Hart, M.; Sticher, Z. M.; Makhsous, N.; Plesker, R.; Barrena, A. H.; Reddy, P. G.; Mitchell, D. G.; et al. Characterization of Orally Efficacious Influenza Drug with High Resistance Barrier in Ferrets and Human Airway Epithelia. Sci. Transl. Med. 2019, 11, 5866. DOI: 10.1126/scitranslmed.aax5866.
  • Rosenke, K.; Hansen, F.; Schwarz, B.; Feldmann, F.; Haddock, E.; Rosenke, R.; Barbian, K.; White, K. M.; Okumura, A.; Leventhal, S.; et al. Orally Delivered MK-4482 Inhibits SARS-CoV-2 Replication in the Syrian Hamster. Nat. Commun. 2021, 12, 2295.
  • Pastuch-Gawolek, G.; Bieg, T.; Szeja, W.; Flasz, J. 5-Amino-2-Pyridyl 1-Thioglycosides in Synthesis of Analogs of Glycosyltransferases Substrates. Bioorg. Chem. 2009, 37, 77–83.
  • Pastuch-Gawolek, G.; Chaubey, B.; Szewczyk, B.; Krol, E. Novel Thioglycosyl Analogs of Glycosyltransferase Substrates as Antiviral Compounds against Classical Swine Fever Virus and Hepatitis C Virus. Eur. J. Med. Chem. 2017, 137, 247–262.
  • Abu-Zaied, M. A.; Elgemeie, G. H.; Mahmoud, N. M. Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents against SARS-COV-2 and Avian Influenza H5N1 Viruses. Am. Chem. Soc. (Omega) 2021, 6, 16890–16904.
  • Abu-Zaied, M. A.; Mahmoud, N. M.; Elgemeie, G. H. Synthesis of Novel Pyrimidine Thioglycosides as Structural Analogs of Favipiravir (Avigan) and Their Antibird Flu Virus Activity. Nucleosides. Nucleotides Nucleic Acids 2021, 40, 336–356.
  • Abu-Zaied, M. A.; Mahmoud, N. M.; Elgemeie, G. H. Toward Developing Therapies against Corona Virus: Synthesis and anti-Avian Influenza Virus Activity of Novel Cytosine Thioglycoside Analogues. Am. Chem. Soc. (Omega) 2020, 5, 20042–20050.
  • Azzam, R. A.; Osman, R. R.; Elgemeie, G. H. Efficient Synthesis and Docking Studies of Novel Benzothiazole-Based Pyrimidinesulfonamide Scaffolds as New Antiviral Agents and Hsp90α Inhibitors. Am. Chem. Soc. (Omega) 2020, 5, 1640–1655.
  • Azzam, R. A.; Elsayed, R. E.; Elgemeie, G. H. Design and Synthesis of a New Class of Pyridine-Based N-Sulfonamides Exhibiting Antiviral, Antimicrobial, and Enzyme Inhibition Characteristics. ACS Omega 2020, 5, 26182–26194. DOI: 10.1021/acsomega.0c03773.
  • Hebishy, A. M. S.; Salama, H. T.; Elgemeie, G. H. New Route to the Synthesis of Benzamide-Based 5-Aminopyrazoles and Their Fused Heterocycles Showing Remarkable Antiavian Influenza Virus Activity. ACS Omega 2020, 5, 25104–25112. DOI: 10.1021/acsomega.0c02675.
  • Azzam, R. A.; Elboshi, H. A.; Elgemeie, G. H. Novel Synthesis and Antiviral Evaluation of New Benzothiazole-Bearing N-Sulfonamide 2-Pyridone Derivatives as USP7 Enzyme Inhibitors. ACS Omega 2020, 5, 30023–30036. DOI: 10.1021/acsomega.0c04424.
  • Azzam, R. A.; Elgemeie, G. H.; Osman, R. R. Synthesis of Novel Pyrido[2,1-b]Benzothiazole and N-Substituted 2-Pyridylbenzothiazole Derivatives Showing Remarkable Fluorescence and Biological Activities. J. Mol. Struct. 2020, 1201, 127194–127224. DOI: 10.1016/j.molstruc.2019.127194.
  • Azzam, R. E.; Elsayed, R. E.; Elgemeie, G. H. Design, Synthesis, and Antimicrobial Evaluation of a New Series of N-Sulfonamide 2-Pyridones as Dual Inhibitors of DHPS and DHFR Enzymes. ACS Omega 2020, 5, 10401–10414. DOI: 10.1021/acsomega.0c00280.
  • Metwally, N. H.; Elgemeie, G. H.; Jones, P. G. Crystal Structure of Ethyl 2-(5-amino-1-benzene-sulfonyl-3-oxo-2,3-di-hydro-1H-pyrazol-2-yl)acetate. Acta Crystallogr. E Crystallogr. Commun. 2020, 76, 481–483. DOI: 10.1107/S2056989020002674.
  • Mohamed-Ezzat, R. A.; Elgemeie, G. H.; Jones, P. G. Crystal Structures of (E)-2-amino-4-methyl-sulfanyl-6-oxo-1-(1-phenyl-ethyl-idene-amino)-1,6-di-hydro-pyrimidine-5-carbo-nitrile and (E)-2-amino-4-methyl-sulfanyl-6-oxo-1-[1-(pyridin-2-yl)ethyl-idene-amino]-1,6-di-hydro-pyrimidine-5-carbo-nitrile. Acta Crystallogr. E Crystallogr. Commun. 2021, 77, 547–550. DOI: 10.1107/S2056989021004126.
  • Elgemeie, G. H.; Azzam, R. A.; Elsayed, R. A. Sulfa Drug Analogs: New Classes of N-Sulfonyl Aminated Azines and Their Biological and Preclinical Importance in Medicinal Chemistry (2000-2018). Med. Chem. Res. 2019, 28, 1099–1131. DOI: 10.1007/s00044-019-02378-6.
  • Metwally, N. H.; Elgemeie, G. H.; Jones, P. G. Crystal Structure of Ethyl 2-(3-amino-5-oxo-2-tosyl-2,5-di-hydro-1H-pyrazol-1-yl)acetate. Acta Crystallogr. E Crystallogr. Commun. 2021, 77, 615–617. DOI: 10.1107/S2056989021004795.
  • Elgemeie, G.; Abou-Zeid, M.; Alsaid, S.; Hebishy, A.; Essa, H. Novel Nucleoside Analogues: First Synthesis of Pyridine-4-Thioglycosides and Their Cytotoxic Evaluation. Nucleosides Nucleotides Nucleic Acids 2015, 34, 659–673. DOI: 10.1080/15257770.2015.1071843.
  • Elgemeie, G.; Fathy, N.; Zaghary, W.; Farag, A. Novel Synthesis of Dihydropyridine Thioglycosides and Their Cyctotoxic Activity. Nucleosides Nucleotides 2017, 36, 198–212. DOI: 10.1080/15257770.2016.1257807.
  • Elgemeie, G. H.; Farag, A. B. Design, Synthesis, and in Vitro antiHepatocellular Carcinoma of Novel Thymine Thioglycoside Analogs as New Antimetabolic Agents. Nucleosides. Nucleotides Nucleic Acids 2017, 36, 355–377.
  • Elgemeie, G. H.; Alkhursani, S. A.; Mohamed, R. A. New Synthetic Strategies for Acyclic and Cyclic Pyrimidinethione Nucleosides and Their Analogues. Nucleosides Nucleotides Nucleic Acids 2019, 38, 12–87. DOI: 10.1080/15257770.2018.1498511.
  • Elgemeie, G. H.; Abu-Zaied, M. A.; Loutfy, S. A. 4-Aminoantipyrine in Carbohydrate Research: Design, Synthesis and Anticancer Activity of a Novel Class of Derivatives of 4-Aminoantipyrine Thioglycosides and Their Corresponding Pyrazolopyrimidine and Pyrazolopyridine Thioglycosides. Tetrahedron 2017, 73, 5853–5861. DOI: 10.1016/j.tet.2017.08.024.
  • Abu-Zaied, M. A.; Loutfy, S. A.; Hassan, A. E.; Elgemeie, G. H. Novel Purine Thioglycoside Analogs: Synthesis, Nanoformulation and Biological Evaluation in in-Vitro Human Liver and Breast Cancer Models. Drug Des. Devel. Ther. 2019, 13, 2437–2457. DOI: 10.2147/DDDT.S201249.
  • Elgemeie, G. H.; El-Enany, M. M.; Ismail, M. M.; Ahmed, E. K. Nucleic Acid Components and Their Analogues: A Novel and Efficient Method for the Synthesis of a New Class of Bipyridyl and BiheterocyclicNitrogen Thioglycosides from Pyridine-2(1H)-Thiones. Nucleosides. Nucleotides Nucleic Acids 2002, 21, 477–493.
  • Abu-Zaied, M. A.; Elgemeie, G. H. Synthesis of the First Novel Pyrazole Thioglycosides as Deaza Ribavirin Analogues. Nucleosides. Nucleotides Nucleic Acids 2017, 36, 713–725.
  • Abu-Zaied, M. A.; Elgemeie, G. H. Thiazoles in Glycosylation Reactions: Novel Synthesis of Thiazole Thioglycosides. Heteroatom Chem. 2017, 28, e21404. DOI: 10.1002/hc.21404.
  • Abu-Zaied, M. A.; El-Telbani, E. M.; Elgemeie, G. H.; Nawwar, G. A. Synthesis and in Vitro anti-Tumor Activity of New Oxadiazole Thioglycosides. Eur. J. Med. Chem. 2011, 46, 229–235.
  • Elgemeie, G. H.; Farag, A. B.; Amin, K. M.; El-Badry, O. M.; Hassan, G. S. Design, Synthesis and Cytotoxic Evaluation of Novel Heterocyclic Thioglycosides. Med. Chem. 2014, 4, 814–820.
  • Elgemeie, G. H.; Abu-Zaied, M. A.; Nawwar, G. A. First Novel Synthesis of Triazole Thioglycosides as Ribavirin Analogues. Nucleosides Nucleotides Nucleic Acids 2018, 37, 112–123. DOI: 10.1080/15257770.2017.1423079.
  • Elgemeie, G. H.; Fathy, N. M.; Farag, A. B.; Bin Yahab, A. M. Design and Synthesis of a New Class of Indeno[1,2-b]Pyridine Thioglycosides. Nucleosides & Nucleotides 2020, 39, 1134–1149. DOI: 10.1080/15257770.2020.1780436.
  • Elgemeie, G. H.; Zaghary, W. A.; Amin, K. M.; Nasr, T. M. First Synthesis of Thienopyrazole Thioglycosides. J. Carbohydrate Chem. 2008, 27, 345–356. DOI: 10.1080/07328300802236178.
  • Abu-Zaied, M. A.; Hammad, S. F.; Halaweish, F. T.; Elgemeie, G. H. Sofosbuvir Thio-Analogues: Synthesis and Antiviral Evaluation of the First Novel Pyridine- and Pyrimidine-Based Thioglycoside Phosphoramidates. ACS Omega 2020, 5, 14645–14655. DOI: 10.1021/acsomega.0c01364.
  • Abu-Zaied, M. A.; Elgemeie, G. H.; Jones, P. G. Crystal Structure of 4,6-Dimethyl-2-[(2,3,4,6-tetra-O-Acetyl-β-D-Galactopyranosyl) Sulfanyl] Pyrimidine. Acta Cryst. 2019, E75, 1820–1823.
  • Hammad, S. F.; Masoud, D. M.; Elgemeie, G. H.; Jones, P. G. Crystal Structure of Racemic 2-[(β-Arabinopyranosyl)Sulfanyl]-4,6-Diphenylpyridine-3-Carbonitrile. Acta Cryst. 2018, E74, 853–856.
  • Mossman, T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods 1983, 65, 55–63.
  • Hayden, F. G.; Cote, K. M.; Douglas, R. G. Plaque Inhibition Assay for Drug Susceptibility Testing of Influenza Viruses. Antimicrob. Agents Chemother. 1980, 17, 865–870. DOI: 10.1128/AAC.17.5.865.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.